Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.610
-0.070 (-4.15%)
Nov 17, 2026, 9:39 AM EST - Market open
Purple Biotech Employees
Purple Biotech had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$2,449,300
Market Cap
10.05M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 1 | 11.11% | 10 | 0 |
| Dec 31, 2024 | 9 | -11 | -55.00% | 9 | 0 |
| Dec 31, 2023 | 20 | 0 | - | 20 | 0 |
| Dec 31, 2022 | 20 | 1 | 5.26% | 20 | 0 |
| Dec 31, 2021 | 19 | 6 | 46.15% | 19 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| CytoMed Therapeutics | 42 |
| Palatin Technologies | 25 |
| BioLineRx | 24 |
| Lisata Therapeutics | 21 |
| Radiopharm Theranostics | 14 |
| Cellectar Biosciences | 11 |
| Intensity Therapeutics | 7 |
PPBT News
- 2 hours ago - Purple Biotech Reports Third Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 19 days ago - Purple Biotech Announces IM1240 Abstract Selected for Oral Presentation at the 38th EORTC-NCI-AACR Symposium - GlobeNewsWire
- 2 months ago - Why Is Purple Biotech (PPBT) Stock 42% Up Today? - TipRanks
- 2 months ago - Purple Biotech issued notice of allowance from USPTO - TheFly
- 2 months ago - New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies - GlobeNewsWire
- 3 months ago - Purple Biotech price target lowered to $17 from $30 at H.C. Wainwright - TheFly
- 5 months ago - Purple Biotech presents new IM1240 data at EACR - TheFly
- 6 months ago - Purple Biotech files $200M mixed securities shelf - TheFly